Protocol Ledger

NCT06548971 · Phase III · RECRUITING

Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)

Interventional Phase III clinical trial protocol NCT06548971 sponsored by Capital Medical University in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-11-07 Enrollment: 1,184 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06548971
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,184 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06548971
Protocol FieldVerified Registry Value
NCT IdentifierNCT06548971
Consolidated Lead SponsorCapital Medical University
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment1,184 participants (ESTIMATED)
Registered Start Date2024-11-07
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06548971
Hospital Research SiteLocationSite Profile
Xuanwu Hospital Capital Medical UniversityBeijing, ChinaOpen Hospital Dossier ->
The First Affiliated Hospital of Xiamen UniversityXiamen, ChinaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI